Yuhan Corp 000100
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₩86,600.00
- Day Range
- ₩82,800.00–86,500.00
- 52-Week Range
- ₩65,000.00–129,200.00
- Bid/Ask
- ₩82,900.00 / ₩84,000.00
- Shares Outstanding
- 74.76M
- Market Cap
- ₩6.28T
- Volume/Avg
- 340,784 / 273,095
Key Statistics
- Price/Earnings (Normalized)
- 33.48
- Price/Sales
- 2.73
- Dividend Yield (Trailing)
- 0.71%
- Dividend Yield (Forward)
- 0.71%
- Dividend Payment Schedule
- Apr
- Total Yield
- 0.71%
Company Profile
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplements, household and animal care, and contract manufacturing of active pharmaceutical ingredients. The company offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,123
- Website
- https://www.yuhan.co.kr
Valuation
|
Metric
|
000100
|
|---|---|
Price/Earnings (Normalized) | 33.48 |
Price/Book Value | 2.63 |
Price/Sales | 2.73 |
Price/Cash Flow | 25.24 |
Price/Earnings
000100
Financial Strength
|
Metric
|
000100
|
|---|---|
Quick Ratio | 1.62 |
Current Ratio | 2.27 |
Interest Coverage | 17.89 |
Quick Ratio
000100
Profitability
|
Metric
|
000100
|
|---|---|
Return on Assets (Normalized) | 7.28% |
Return on Equity (Normalized) | 10.20% |
Return on Invested Capital (Normalized) | 8.84% |
Return on Assets
000100
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|Q?bL!QV$ | LOCK|gL&> | $69B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|w?S^y!?& | LOCK|%l>H | $47B | |||
| Haleon PLC ADR
HLN
| LOCK|rpYZzqr | LOCK|%@ | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|B<#fgJG | LOCK|!>l | $33B | |||
| Viatris Inc
VTRS
| LOCK|s%S>Y@! | LOCK|^CR | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|?l | LOCK|%LN | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|C@L&Yl | LOCK|>x | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|R%V%Yn! | LOCK|sg | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|ckDxGlb | LOCK|fn%J | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|#kxdw< | LOCK|l% | $2B |
United States